SPRY
ARS Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $927.98M | Price | $8.96 |
| Volume | 2.08M | Change | +3.94% |
| P/E Ratio | 116.0 | Open | $8.62 |
| Revenue | $89.1M | Prev Close | $8.62 |
| Net Income | $8.0M | 52W Range | $8.45 - $18.90 |
| Div Yield | N/A | Target | $31.00 |
| Overall | 32 | Value | 55 |
| Quality | -- | Technical | 10 |
No chart data available
Stock Overview
Updated DailyARS Pharmaceuticals Inc. (SPRY) is a leading diversified company in the business industry, currently trading at $8.96 with a market capitalization of $927.98 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows SPRY with a volume of 2.08 million shares. The stock opened down 0.00% from yesterday's close of $8.62. Current analyst estimates project earnings of $-1.65 per share for this year, with next year targeting $-0.78.
SPRY demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange.
Key investment considerations for SPRY include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 246.0%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 2, 2025 at 08:07 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SPRY | $8.96 | +3.9% | 2.08M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ARS Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW